A Promising Frontier in Cancer Therapy — Combining Endothelial Colony Forming Cells, Nanotechnology, and Hyperthermia for Precision Oncology

David M. Smadja; David M. Smadja; Alexandre G. Lellouch; Alexandre G. Lellouch

doi:10.1007/s12015-025-10974-w

Article2011

Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony‐forming cells properties

Zahia Benslimane-Ahmim, Zahia Benslimane-Ahmim, Dominique Heymann, Dominique Heymann, Blandine Dizier, Blandine Dizier, Anna Lokajczyk, Anna Lokajczyk, Régis Brion, Régis Brion, Ingrid Laurendeau, Ingrid Laurendeau, Ivan Bièche, Ivan Bièche, David M. Smadja, David M. Smadja, Isabelle Galy–Fauroux, Isabelle Galy–Fauroux, Sylvia Colliec‐Jouault, Sylvia Colliec‐Jouault, Alec M. Fischer, Alec M. Fischer, Catherine Boisson‐Vidal, Catherine Boisson‐Vidal

Article2017

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction

José Rubicel Hernández-López, José Rubicel Hernández-López, Antonieta Chávez‐González, Antonieta Chávez‐González, Patricia Torres-Barrera, Patricia Torres-Barrera, Dafné Moreno-Lorenzana, Dafné Moreno-Lorenzana, Norma Edith López‐Díazguerrero, Norma Edith López‐Díazguerrero, David Santiago-Germán, David Santiago-Germán, Irma Isordia‐Salas, Irma Isordia‐Salas, David M. Smadja, David M. Smadja, Mervin C. Yöder, Mervin C. Yöder, Abraham Majluf‐Cruz, Abraham Majluf‐Cruz,

Article2017

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction

José Rubicel Hernández-López, José Rubicel Hernández-López, Antonieta Chávez‐González, Antonieta Chávez‐González, Patricia Torres-Barrera, Patricia Torres-Barrera, Dafné Moreno-Lorenzana, Dafné Moreno-Lorenzana, Norma Edith López‐Díazguerrero, Norma Edith López‐Díazguerrero, David Santiago-Germán, David Santiago-Germán, Irma Isordia‐Salas, Irma Isordia‐Salas, David M. Smadja, David M. Smadja, Mervin C. Yöder, Mervin C. Yöder, Abraham Majluf‐Cruz, Abraham Majluf‐Cruz,

Article2023

Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties

David M. Smadja, David M. Smadja, Elisa Rossi, Elisa Rossi, Skerdi Haviari, Skerdi Haviari, Ivan Bièche, Ivan Bièche, Audrey Cras, Audrey Cras, Pascale Gaussem, Pascale Gaussem

Article2020

Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process

Nathalie Névo, Nathalie Névo, Séverine Lecourt, Séverine Lecourt, Ivan Bièche, Ivan Bièche, Magda Kucia, Magda Kucia, Audrey Cras, Audrey Cras, Adeline Blandinières, Adeline Blandinières, Sophie Vacher, Sophie Vacher, Nicolas Gendron, Nicolas Gendron, Coralie L. Guérin, Coralie L. Guérin, Mariusz Z. Ratajczak, Mariusz Z. Ratajczak, David M. Smadja, David M. Smadja

A Promising Frontier in Cancer Therapy — Combining Endothelial Colony Forming Cells, Nanotechnology, and Hyperthermia for Precision Oncology

Discussion(0)

Related publications

Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony‐forming cells properties

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction

Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties

Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process